Skare Thelma L, Freire de Carvalho Jozélio
Department of Rheumatology, Hospital Evangélico Mackenzie, Curitiba, PR, Brazil.
Nuclei for Research on Chronic Non-Transmissible Diseases (NUPEC), Federal University of Bahia School of Nutrition, Salvador, Brazil.
Eur J Rheumatol. 2025 Mar 10;12(1):1-24. doi: 10.5152/eurjrheum.2025.23076.
Hearing loss may be found in patients with systemic autoimmune disorders such as connective tissue diseases (CTD). This work aimed to review the literature on ear involvement in CTD. A systematic search of articles published in PubMed/MEDLINE, EMBASE, and SCOPUS from 1966 to June 2023 following PRISM guidelines was done. Seventy-nine papers were selected: 39 on rheumatoid arthritis; 16 on systemic lupus erythematosus; 14 on scleroderma; 6 on Sjogren's syndrome; 1 on mixed connective tissue disease; and 3 that approached more than one CTD. Most of them showed that hearing loss (HL) in connective tissue disease patients was higher than in controls, mainly of the sensorineural type and at high frequencies. Associations with clinical features and autoantibodies profile of underlying conditions varied widely among the results. In conclusion, sensorineural hearing loss is common in individuals with CTD, and it is essential to be aware of this complication in order to establish an effective treatment.
听力损失可能在患有系统性自身免疫性疾病的患者中出现,如结缔组织病(CTD)。这项工作旨在回顾关于CTD耳部受累的文献。按照PRISM指南,对1966年至2023年6月在PubMed/MEDLINE、EMBASE和SCOPUS上发表的文章进行了系统检索。共筛选出79篇论文:39篇关于类风湿关节炎;16篇关于系统性红斑狼疮;14篇关于硬皮病;6篇关于干燥综合征;1篇关于混合性结缔组织病;3篇涉及不止一种CTD。其中大多数研究表明,结缔组织病患者的听力损失(HL)高于对照组,主要为感音神经性听力损失且发生在高频。结果中,听力损失与潜在疾病的临床特征和自身抗体谱之间的关联差异很大。总之,感音神经性听力损失在CTD患者中很常见,认识到这一并发症对于建立有效的治疗方法至关重要。